What is NTNX's health score?

Nutanix, Inc. (NTNX) has a TradeApes health score of 61 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is NTNX's estimated fair value?

Based on our 5-year discounted cash flow model, Nutanix, Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is NTNX undervalued or overvalued?

Our model currently rates NTNX as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for NTNX... Refresh in a moment for the full analysis.

Nutanix, Inc. (NTNX)

Technology Inconclusive inconclusive healthy

$53.64

Updated: 2026-06-06

TradeApes Score

Financial Strength

70 Healthy

Operating Trend

55 Mixed

Relative Value

75 Strong

Capital Allocation

40 Weak

Risk

50 Mixed

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Altman Z-Score in distress zone — elevated bankruptcy risk

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.